New sedative may offer safer heart scans
NCT ID NCT06129188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new FDA-approved sedative, remimazolam, against the standard drug propofol for people having a heart ultrasound called TEE. The goal was to see if remimazolam keeps blood pressure and heart rate more stable. 105 adults took part, and researchers measured vital signs and sedation levels during the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham Hospital
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a ketamine boost during surgery slash opioid needs?
- Can a wearable glucose sensor survive the operating room?
- Can a scalp cap read the brain as well as implanted wires?
- Can a High-Tech numbing method ease Kids' dental fear?
- Which nerve block eases Children's heart surgery pain better?